Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

575 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A Phase II Study of Ibrutinib in Advanced Neuroendocrine Neoplasms.
Al-Toubah T, Schell MJ, Cives M, Zhou JM, Soares HP, Strosberg JR. Al-Toubah T, et al. Among authors: zhou jm. Neuroendocrinology. 2020;110(5):377-383. doi: 10.1159/000502383. Epub 2019 Jul 30. Neuroendocrinology. 2020. PMID: 31357193 Free PMC article. Clinical Trial.
Completion of adjuvant therapy in patients with resected pancreatic cancer.
DePeralta DK, Ogami T, Zhou JM, Schell MJ, Powers BD, Hodul PJ, Malafa MP, Fleming JB. DePeralta DK, et al. Among authors: zhou jm. HPB (Oxford). 2020 Feb;22(2):241-248. doi: 10.1016/j.hpb.2019.07.008. Epub 2019 Sep 25. HPB (Oxford). 2020. PMID: 31563326 Free PMC article.
Phase I Clinical Trial of Selinexor in Combination with Daunorubicin and Cytarabine in Previously Untreated Poor-Risk Acute Myeloid Leukemia.
Sweet K, Komrokji R, Padron E, Cubitt CL, Turner JG, Zhou J, List AF, Sallman DA, Dawson JL, Sullivan DM, Chavez J, Shah BD, Lancet JE. Sweet K, et al. Clin Cancer Res. 2020 Jan 1;26(1):54-60. doi: 10.1158/1078-0432.CCR-19-2169. Epub 2019 Oct 21. Clin Cancer Res. 2020. PMID: 31636097 Free PMC article. Clinical Trial.
Aberrant Epidermal Growth Factor Receptor RNA Splice Products Are Among the Most Frequent Somatic Alterations in Clear Cell Renal Cell Carcinoma and Are Associated with a Poor Response to Immunotherapy.
Zaman S, Hajiran A, Coba GA, Robinson T, Madanayake TW, Segarra DT, Chobrutskiy BI, Boyle TA, Zhou JM, Kim Y, Mulé JJ, Teer JK, Manley BJ. Zaman S, et al. Among authors: zhou jm. Eur Urol Focus. 2021 Mar;7(2):373-380. doi: 10.1016/j.euf.2019.12.001. Epub 2019 Dec 31. Eur Urol Focus. 2021. PMID: 31901438 Free PMC article.
575 results